Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study

Patients with cold agglutinin disease (CAD) experience fatigue and poor quality of life. However, previous CAD-related studies have not explored patient-reported outcomes such as the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue. Sutimlimab, a C1s complement inhibitor, has been sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Röth, Alexander, Barcellini, Wilma, Tvedt, Tor Henrik Anderson, Miyakawa, Yoshitaka, Kuter, David J., Su, Jun, Jiang, Xiaoyu, Hobbs, William, Arias, Jaime Morales, Shafer, Frank, Weitz, Ilene C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463238/
https://www.ncbi.nlm.nih.gov/pubmed/35999387
http://dx.doi.org/10.1007/s00277-022-04948-y

Ejemplares similares

Ejemplares similares